[Low-flow membrane blood gas exchange in the treatment of chronic respiratory insufficiency].
The results of experimental and clinical studies provide evidence that the developed method for treating chronic respiratory failure, i.e. low-flow extracorporeal membranous blood gas exchange, is a pathogenetic method for the management of respiratory failure. Its action is effected through improvement of the organism's oxygen regiment, partial CO2 elimination, improvement of hemodynamic and hemorheological parameters, prevention of damage to lung ultrastructure induced by respiratory failure.